Department of Ophthalmology (M.M.S., C.B.N.), Mayo Clinic, Rochester, MN; Illinois College of Optometry (J.H.), Chicago, IL; Department of Ophthalmology and Vision Sciences (E.S.), University of Illinois at Chicago, Chicago, IL; Korb and Associates (A.N.), Boston, MA; and The Ohio State University (J.F.), Columbus, OH.
Address correspondence to Muriel M. Schornack, OD, Department of Ophthalmology, Mayo Clinic, 200 First St SW, Rochester, MN 55905; e-mail: [email protected]
The authors have no competing interests to declare.
Contamac provided an unrestricted grant to the SCOPE study group to support survey development and distribution. Study design, data collection, data analysis, interpretation of data, writing of the report, and decision to submit the article for publication were completed by the authors independently. This publication was supported, in part, by the National Center for Advancing Translational Sciences of the National Institutes of Health under Grant UL1TR002733. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The study also received support from the National Eye Institute Center Core Grant P30 EY001792hT and an unrestricted grant from Research to Prevent Blindness.
